メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
第４・心臓血管外科
病院局
岡崎医療センター
概要
フィンガープリント
ネットワーク
研究成果
(23)
フィンガープリント
第４・心臓血管外科が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Aortic Dissection
100%
Aneurysm
83%
Thrombosis
66%
Blood Plasma
66%
Heart Myxoma
66%
Valve Deterioration
66%
Enolase
66%
Open Heart Surgery
66%
Endovascular Aneurysm Repair
66%
Aortic Arch
66%
Diabetes Mellitus
66%
Left Ventricular Assist Device
66%
Aortic Surgery
66%
Beta Chain
51%
QT Dispersion
40%
Aortic Valve
33%
Surgical Anastomosis
33%
Operative Complication
33%
Computer Assisted Tomography
33%
Descending Aorta
33%
Reoperation
33%
Ascending Aorta Surgery
33%
Thoracic Aorta
33%
Surgical Infection
33%
Idiopathic Interstitial Pneumonia
33%
Malperfusion Syndrome
22%
Mesenteric Artery Occlusion
22%
Hospital Mortality
17%
Pseudoephedrine Plus Triprolidine
16%
Blood Stasis
16%
Ceramide Trihexoside
16%
Aortic Valve Disease
16%
Alpha-Galactosidase
16%
Long Term Survival
16%
Aneurysm Rupture
16%
Stent-Graft
16%
Skeletal Muscle
14%
Adverse Event
14%
Patient with Diabetes
14%
Infection
14%
Ischemic Mitral Valve Regurgitation
11%
Grafting
9%
Dissecting Aneurysm
9%
Aortic Arch Surgery
9%
Brain Infarction
9%
Surgery
9%
Respiratory Failure
9%
Thoracotomy
9%
Open Surgery
9%
Mortality Rate
8%
Thorax Surgery
8%
Alpha Chain
7%
Carbonate Dehydratase III
7%
Mitral Valve Replacement
7%
Heart Muscle Injury
7%
Enzyme Immunoassay
7%
Coronary Sinus
7%
Immunoassay Method
7%
Isoenzyme
7%
Proportional Hazards Model
7%
Diabetes
7%
Driveline Infection
7%
All Cause Mortality
7%
Postoperative Complication
7%
Blood pH
6%
Keyphrases
β-Enolase
66%
Dispersion Wave
66%
Cardiac Myxoma
66%
Creatine kinase-MM
66%
Transvenous Permanent Pacemaker Implantation
66%
Bio-Bentall
66%
Device Analysis
66%
Chronic Type A Aortic Dissection
33%
Left Atrial Myxoma
22%
Malperfusion Syndrome
22%
Pedunculated Tumor
22%
Left Ventricular Myxoma
22%
Right Superior Pulmonary Vein
22%
Mitral Valve Obstruction
22%
Robust Recommendation
22%
Cardiac Surgeons
22%
α-galactosidase Activity
22%
Pacemaking
22%
Angiokeratoma Corporis Diffusum
22%
Severe Bradycardia
22%
Glycosphingolipid Metabolism
22%
Transvenous Pacemaker
22%
Plasma beta
19%
Extended Arch
19%
Biological Valved Conduit
16%
Sewing
16%
Valve-in-valve
16%
Biological Valve
16%
Aortic Valve Disease
16%
Wave Dispersion
13%
Mitral Annuloplasty
11%
Concomitant Procedures
11%
Left Ventricular Reconstruction
11%
Impaired Left Ventricular Function
11%
M Method
11%
Ischemic Mitral Regurgitation
11%
Entry Closure
11%
Residual Dissection
11%
Blood pH
6%
Proportional Hazards Regression Analysis
6%
Nonparametric Survival Analysis
6%
Coating System
6%
Aortic Cannula
6%
Azygos Vein
6%
Nursing and Health Professions
Left Ventricular Assist Device
66%
Intraaortic Balloon Pump
66%
Central Venous Pressure
66%
Diabetes Mellitus
66%
Oxygenator
66%
QT Dispersion
40%
Tissue Blood Flow
26%
Cerebrospinal Fluid Pressure
20%
Patient with Diabetes
14%
Confidence Interval
14%
Adverse Event
14%
Infection
14%
Membrane Oxygenator
13%
Proportional Hazards Model
7%
Continuous Flow Left Ventricular Assist Device
7%
All Cause Mortality
7%
Driveline Infection
7%
Postoperative Complication
7%
Hydrogen Clearance
6%
Arrhythmogenesis
6%
Heart Lung Machine
6%
Brain Edema
6%